Pharmas Market Video Gallery
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Dr. Steven Nissen, chairman of the Department of Cardiov...
SPECIAL REPORT
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Existing-Home Sales Jump To Highest Level in 2-1/2 Years
- Start-Up Proves Everything Really Is Better With Bacon
- Wave of Debt Payments Facing US Government
- Wall Street Finds Profits by Reducing Mortgages
- Cadbury Hits New High as Bidders Circle
- China Asks Its Banks to Slow Down
- MBS Buyback Program Should be Extended: Fed's Bullard
- Expect a 'Square Root-Shaped' Recovery: Chief Investor
- Madoff—The Holiday Drink
- HP to Feed on Enterprise Spending Next Year: Tech Analyst
- Busch: Markets Smell a Country Rat
- Schork Oil Outlook: Mission Impossible For The Bears?
- S&P Stocks Trading at New 52-Week Highs
- Losey: Asset Allocation At Retirement
- Farrell: Obama Hectored, Ignored and Restricted?
- Don't Dwell on Investment Mistakes; Move on, Like Buffett
- Existing-Home Sales Jump to 2-1/2 Year High
- Wave of Debt Payments Facing US Government
- US Job Losses to Bottom out Next Quarter: NABE
- Obama Jobs Forum May Be More Political Than Practical
- Late Payments on Credit Cards Drop in Third Quarter
- Suze Orman’s 'A Healthier, Wealthier You'
- Latest Holiday Drinks: The Madoff...and the TARPatini
- Madoff Trustee, Law Firm Submit $22.1 Million Bill
- JPMorgan's Dimon Could Succeed Geithner: Report
PHARMA'S MARKET VIDEO
» More

Cholesterol Drug Battle: Niaspan vs. Zetia
16 Nov 2009
Cardiologist Grades Cholesterol Drug Study
16 Nov 2009
Merck's Cholesterol Drugs Under Pressure
16 Nov 2009
Cholesterol Drug Battle: Merck vs. Abbott Labs
16 Nov 2009
Cholesterol Drug Battle
16 Nov 2009
Novo Nordisk CEO on Diabetes Epidemic
13 Nov 2009
RSS FEED
» Help
powered by digg
Pharma's Market
Sep.19
1:59 PM ET
Wednesday, 19 Sep 2007
"Star Wars": Chewbacca's Revenge on Pfizer
Posted By:Mike Huckman
Topics:Movies & Film Studios | Stock Market | Medicine | Corporate News | Corporate Governance | Pharmaceuticals
Sectors:Health Care | Pharmaceuticals
Companies:Pfizer Inc
![]() |
I suspect Les is a "Star Wars" fan because his notes to clients, with all due respect, are often rife with spelling errors and typos, and he got the counterintuitive spelling of "Wookiee" correct. More on that in a moment.
(Full disclosure: I am not a "Star Wars" fan and I had to google Wookiee to double-check the spelling.)
Pfizer [PFE Loading... ()
At a scientific conference in Chicago this week, a researcher presented the results of a study showing that 12% of the people who take Vfend start seeing things. Like Chewy. Yep, the scientist told doctors at the Interscience Conference on Antimicrobial Agents and Chemotherapy meeting that one patient claims to have had visions of Wookiees after taking Vfend.
So here's Les' hilarious take on all this: "Included in the reported visions was at least one sighting of a Wookiee (presumably Chewbacca). We make the following observations: what is wrong with seeing Wookiees? We are making no changes to our 2007 $700 million sales forecast for Vfend, and continue to believe that sales for the drug can grow at a 10% clip over the next few years. We do not see future FDA action in terms of a black-box Wookiee warning or an FDA Wookiee panel."
May the Pforce be with Pfizer.
Questions? Comments?
© 2009 CNBC, Inc. All Rights Reserved
POPULAR PHARMA'S MARKET POSTS
MORE FROM CNBC










